Veon (VEON) Asset Writedowns and Impairment (2011 - 2026)

Veon (VEON) has reported Asset Writedowns and Impairment for 15 consecutive years, with $2.0 million the latest figure, recorded in Q1 2026.

• Asset Writedowns and Impairment for Q1 2026 came in at $2.0 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.0 million (up 138.46% YoY), and the FY2025 annual result was $9.0 million, up 200.0% from the prior year.
• Asset Writedowns and Impairment was $2.0 million for Q1 2026 at Veon, roughly flat from $2.0 million in the prior quarter.
• Over five years, Asset Writedowns and Impairment peaked at $7.0 million in Q2 2023 and troughed at -$34.0 million in Q4 2022.
• Average Asset Writedowns and Impairment over 5 years is -$6.2 million, with a median of $500000.0 recorded in 2024.
• Year-over-year, Asset Writedowns and Impairment sank 580.0% in 2022 and jumped 153.85% in 2023.
• Over 5 years, Asset Writedowns and Impairment stood at -$34.0 million in 2022, then surged by 120.59% to $7.0 million in 2023, then sank by 114.29% to -$1.0 million in 2024, then jumped by 300.0% to $2.0 million in 2025, then changed by 0.0% to $2.0 million in 2026.
• Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $2.0 million in Q1 2026, $2.0 million in Q1 2025, and -$1.0 million in Q2 2024.